WO2022263498 - SUBSTITUTED PYRAZOLE AMIDES
National phase entry:
Publication Number
WO/2022/263498
Publication Date
22.12.2022
International Application No.
PCT/EP2022/066286
International Filing Date
15.06.2022
Title **
[English]
SUBSTITUTED PYRAZOLE AMIDES
[French]
AMIDES DE PYRAZOLE SUBSTITUÉS
Applicants **
GRÜNENTHAL GMBH
Inventors
KRÜGER, Sebastian
KONETZKI, Ingo
SITNIKOV, Nikolay
YOUNG, Clint
HAGENDORF, Silke
ALEN, Jo
PETTERSSON, Martin
PEIL, Sebastian
DIALER, Clemens
MÜLBAIER, Marcel
WAGENER, Markus
Priority Data
21179636.2
15.06.2021
EP
63/210,607
15.06.2021
US
63/273,417
29.10.2021
US
63/341,107
12.05.2022
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3501 | |
| EPO | Filing, Examination, Granting | 13927 | |
| Japan | Filing, Examination, Granting | 2214 | |
| South Korea | Filing, Examination, Granting | 2300 | |
| USA | Filing, Examination, Granting | 6090 |
Total:
28,032
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present invention relates to compounds according to general formula (I) which act as inhibitors of NaV1.8 and can be used in the treatment of pain.[French]
La présente invention concerne des composés selon la formule générale (I) qui agissent en tant qu'inhibiteurs de NaV1.8 et peuvent être utilisés dans le traitement de la douleur.